199 related articles for article (PubMed ID: 10049258)
1. Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey.
Fielding RM; Moon-McDermott L; Lewis RO; Horner MJ
Antimicrob Agents Chemother; 1999 Mar; 43(3):503-9. PubMed ID: 10049258
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of a small unilamellar low-clearance liposomal amikacin formulation after extravascular administration.
Fielding RM; Moon-McDermott L; Lewis RO
J Drug Target; 1999; 6(6):415-26. PubMed ID: 10937287
[TBL] [Abstract][Full Text] [Related]
3. Altered tissue distribution and elimination of amikacin encapsulated in unilamellar, low-clearance liposomes (MiKasome).
Fielding RM; Lewis RO; Moon-McDermott L
Pharm Res; 1998 Nov; 15(11):1775-81. PubMed ID: 9834002
[TBL] [Abstract][Full Text] [Related]
4. The disposition kinetics, urinary excretion and dosage regimen of amikacin in cross-bred bovine calves.
Saini SP; Srivastava AK
Vet Res Commun; 1998 Jan; 22(1):59-65. PubMed ID: 9541990
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of amikacin in lactating goats.
Abo el-Sooud K
Zentralbl Veterinarmed A; 1999 May; 46(4):239-46. PubMed ID: 10399483
[TBL] [Abstract][Full Text] [Related]
6. The activity of low-clearance liposomal amikacin in experimental murine tuberculosis.
Dhillon J; Fielding R; Adler-Moore J; Goodall RL; Mitchison D
J Antimicrob Chemother; 2001 Dec; 48(6):869-76. PubMed ID: 11733471
[TBL] [Abstract][Full Text] [Related]
7. The early bactericidal activity of a low-clearance liposomal amikacin in pulmonary tuberculosis.
Donald PR; Sirgel FA; Venter A; Smit E; Parkin DP; Van de Wal BW; Mitchison DA
J Antimicrob Chemother; 2001 Dec; 48(6):877-80. PubMed ID: 11733472
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of amikacin in plasma and selected body fluids of healthy horses after a single intravenous dose.
Pinto N; Schumacher J; Taintor J; Degraves F; Duran S; Boothe D
Equine Vet J; 2011 Jan; 43(1):112-6. PubMed ID: 21143642
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
[TBL] [Abstract][Full Text] [Related]
10. Amikacin pharmacokinetics and the effects of ambient temperature on the dosage regimen in ball pythons (Python regius).
Johnson JH; Jensen JM; Brumbaugh GW; Boothe DM
J Zoo Wildl Med; 1997 Mar; 28(1):80-8. PubMed ID: 9226620
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of amikacin in lactating sheep.
Haritova A; Lashev L
Vet Res Commun; 2004 Jul; 28(5):429-35. PubMed ID: 15379437
[TBL] [Abstract][Full Text] [Related]
12. Comparative pharmacokinetics of amikacin following a single intramuscular or subcutaneous administration in goats (Capra hircus).
Uppal RP; Verma SP; Verma V; Garg SK
Vet Res; 1997; 28(6):565-70. PubMed ID: 9428150
[TBL] [Abstract][Full Text] [Related]
13. Incorporation, release and in-vitro antibacterial activity of liposomal aminoglycosides against Pseudomonas aeruginosa.
Omri A; Ravaoarinoro M; Poisson M
J Antimicrob Chemother; 1995 Oct; 36(4):631-9. PubMed ID: 8591937
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: microbiological and echocardiographic analyses.
Xiong YQ; Kupferwasser LI; Zack PM; Bayer AS
Antimicrob Agents Chemother; 1999 Jul; 43(7):1737-42. PubMed ID: 10390232
[TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacokinetics of amikacin in Greyhound and Beagle dogs.
KuKanich B; Coetzee JF
J Vet Pharmacol Ther; 2008 Apr; 31(2):102-7. PubMed ID: 18307501
[TBL] [Abstract][Full Text] [Related]
16. Kinetics and toxicity of liposomal and conventional amikacin in a patient with multidrug-resistant tuberculosis.
Whitehead TC; Lovering AM; Cropley IM; Wade P; Davidson RN
Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):794-7. PubMed ID: 9923523
[TBL] [Abstract][Full Text] [Related]
17. Liposomal amikacin: improved treatment of Mycobacterium avium complex infection in the beige mouse model.
Petersen EA; Grayson JB; Hersh EM; Dorr RT; Chiang SM; Oka M; Proffitt RT
J Antimicrob Chemother; 1996 Nov; 38(5):819-28. PubMed ID: 8961051
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, pulmonary disposition and tolerability of liposomal gentamicin and free gentamicin in foals.
Burton AJ; Giguère S; Arnold RD
Equine Vet J; 2015 Jul; 47(4):467-72. PubMed ID: 24943347
[TBL] [Abstract][Full Text] [Related]
19. A gamma scintigraphy study to investigate lung deposition and clearance of inhaled amikacin-loaded liposomes in healthy male volunteers.
Weers J; Metzheiser B; Taylor G; Warren S; Meers P; Perkins WR
J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):131-8. PubMed ID: 19422313
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and intramuscular bioavailability of amikacin in chickens following single and multiple dosing.
el-Gammal AA; Ravis WR; Krista LM; Tolbert DS; Saad A
J Vet Pharmacol Ther; 1992 Jun; 15(2):133-42. PubMed ID: 1433475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
